Cargando…
VANL-100 Attenuates Beta-Amyloid-Induced Toxicity in SH-SY5Y Cells
Antioxidants are being explored as novel therapeutics for the treatment of neurodegenerative diseases such as Alzheimer’s disease (AD) through strategies such as chemically linking antioxidants to synthesize novel co-drugs. The main objective of this study was to assess the cytoprotective effects of...
Autores principales: | Collins, Andrila E., Saleh, Tarek M., Kalisch, Bettina E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820495/ https://www.ncbi.nlm.nih.gov/pubmed/36613883 http://dx.doi.org/10.3390/ijms24010442 |
Ejemplares similares
-
Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease
por: Collins, Andrila E., et al.
Publicado: (2022) -
Toxicity of amyloid beta 1-40 and 1-42 on SH-SY5Y cell line
por: Krishtal, Jekaterina, et al.
Publicado: (2015) -
Two boron-containing compounds affect the cellular viability of SH-SY5Y cells in an in vitro amyloid-beta toxicity model
por: OZANSOY, Mehmet, et al.
Publicado: (2020) -
A Galantamine–Curcumin Hybrid Decreases the Cytotoxicity of Amyloid-Beta Peptide on SH-SY5Y Cells
por: Mladenova, Kirilka, et al.
Publicado: (2021) -
In vitro evaluation of the protective effects of plant extracts against amyloid-beta peptide-induced toxicity in human neuroblastoma SH-SY5Y cells
por: Sereia, Ana Luiza, et al.
Publicado: (2019)